or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
drug analysis PhD Projects, Programmes & Scholarships
We have 172 drug analysis PhD Projects, Programmes & Scholarships
Innovative Drug Delivery Systems for Ocular Therapies: Micro- and Nano-Formulation Approaches
Ocular drug delivery presents one of the greatest challenges in pharmaceutical science, largely due to the eye’s unique anatomy, which limits drug permeation to the intended site of action. Read more
Self-Assembling Peptide Nanomaterials for Targeted Ocular Drug Delivery
Self-assembling peptide-based hydrogels (SAPH) are composed of short peptide sequences, typically consisting of 5 to 20 amino acids, which undergo spontaneous self-assembly into three-dimensional networks under physiological conditions. Read more
Design and Assessment of Innovative Long-Acting Drug Delivery System
Current clinical therapies often rely on intermittent drug administration, such as frequent oral tablets or injections, as seen in diabetes management. Read more
Non-invasive Therapy for Soft Tissue Reconstruction: Applications in Cosmetics and Wound Healing
Soft tissue reconstruction is emerging as an important strategy to repair and replace diseased or damaged tissue that has been compromised due to tumour removal, injury, trauma, ageing, etc. Read more
Pharmacovigilance and Polypharmacology: Identification of differential side effects within drug classes and links to their unique modes of action
The aim of this study is to determine the differences and potential mechanistic rationale for observed adverse drug reactions (ADRs) in a series of related drug classes. Read more
Development and Evaluation of Microneedle Arrays for Ocular Drug Delivery
Minimally invasive microneedles (MNs) offer unique opportunities to address current challenges in the effective management of ocular disorders, such as age-related macular degeneration and diabetic retinopathy. Read more
Elucidating novel anti-cancer drug responses in advanced ovarian cancer
Ovarian cancer is one of the most lethal gynaecological malignancies, often diagnosed at advanced stages due to non-specific symptoms and a lack of early detection methods. Read more
Precision Medicine DTP - Systematic evidence-based approach to identifying and tailoring inflammation modulating treatments for patients with intracerebral haemorrhage
Research Group:
Centre for Clinical Brain Sciences
Additional supervisor. Prof Tom Van Agtmael (University of Glasgow). Background. Read more
Assessment of drug exposure and prediction of the risk of diabetic retinopathy in type 2 diabetic patients using electronic health records data
Recent figures from Diabetes UK show that 4.3 million people in the UK are diagnosed with diabetes of whom approximately 90% have type 2 diabetes mellitus (T2DM) and another 2.4 million are at high risk of developing the T2DM. Read more
Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
Research Group:
Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs). Read more
Development of anti-inflammatory-based nanoparticles for topical treatment of psoriasis
Psoriasis remains one of the most common forms of skin related autoimmune diseases with more than 4% of prevalence in the developed world. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: Developing new modes of anti-cancer drug delivery using tissue engineered cancer and mass spectrometry imaging
The incidence of oral squamous cell carcinoma (OSCC) in the UK has risen by 60% in the last decade. Treatment for OSCC is surgery followed by radio- or intravenous chemotherapy with the latter having profound off-target toxicity. Read more
Polysialyltransferases as a target in metastatic cancer
Research Group:
Institute of Cancer Therapeutics
Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases. Read more
Nanoprecision in antibiotic delivery using targeted nanoparticles
Gram-negative bacterial species, including E. coli, are major causes of infectious diseases worldwide and account for all organisms in the “critical” category of the WHO list of antibiotic-resistant "priority pathogens". Read more